Spigen Korea Co.,Ltd

KOSDAQ:A192440 Stock Report

Market Cap: ₩116.8b

Spigen KoreaLtd Balance Sheet Health

Financial Health criteria checks 6/6

Spigen KoreaLtd has a total shareholder equity of ₩488.6B and total debt of ₩0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are ₩546.5B and ₩57.9B respectively. Spigen KoreaLtd's EBIT is ₩25.9B making its interest coverage ratio -3.3. It has cash and short-term investments of ₩173.6B.

Key information

0%

Debt to equity ratio

₩0

Debt

Interest coverage ratio-3.3x
Cash₩173.59b
Equity₩488.59b
Total liabilities₩57.92b
Total assets₩546.51b

Recent financial health updates

Does Spigen Korea (KOSDAQ:192440) Have A Healthy Balance Sheet?

Feb 02
Does Spigen Korea (KOSDAQ:192440) Have A Healthy Balance Sheet?

Recent updates

Earnings Working Against Spigen Korea Co.,Ltd's (KOSDAQ:192440) Share Price

Aug 08
Earnings Working Against Spigen Korea Co.,Ltd's (KOSDAQ:192440) Share Price

Shareholders Are Optimistic That Spigen Korea (KOSDAQ:192440) Will Multiply In Value

Apr 13
Shareholders Are Optimistic That Spigen Korea (KOSDAQ:192440) Will Multiply In Value

Spigen Korea Co., Ltd.'s (KOSDAQ:192440) Attractive Combination: Does It Earn A Place In Your Dividend Portfolio?

Mar 30
Spigen Korea Co., Ltd.'s (KOSDAQ:192440) Attractive Combination: Does It Earn A Place In Your Dividend Portfolio?

Spigen Korea Co., Ltd.'s (KOSDAQ:192440) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Mar 15
Spigen Korea Co., Ltd.'s (KOSDAQ:192440) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Is Spigen Korea Co., Ltd. (KOSDAQ:192440) Popular Amongst Insiders?

Mar 01
Is Spigen Korea Co., Ltd. (KOSDAQ:192440) Popular Amongst Insiders?

Spigen Korea (KOSDAQ:192440) Shareholders Have Enjoyed A 42% Share Price Gain

Feb 16
Spigen Korea (KOSDAQ:192440) Shareholders Have Enjoyed A 42% Share Price Gain

Does Spigen Korea (KOSDAQ:192440) Have A Healthy Balance Sheet?

Feb 02
Does Spigen Korea (KOSDAQ:192440) Have A Healthy Balance Sheet?

Is Now The Time To Put Spigen Korea (KOSDAQ:192440) On Your Watchlist?

Jan 20
Is Now The Time To Put Spigen Korea (KOSDAQ:192440) On Your Watchlist?

What Do The Returns On Capital At Spigen Korea (KOSDAQ:192440) Tell Us?

Jan 07
What Do The Returns On Capital At Spigen Korea (KOSDAQ:192440) Tell Us?

Is It Smart To Buy Spigen Korea Co., Ltd. (KOSDAQ:192440) Before It Goes Ex-Dividend?

Dec 25
Is It Smart To Buy Spigen Korea Co., Ltd. (KOSDAQ:192440) Before It Goes Ex-Dividend?

Will Weakness in Spigen Korea Co., Ltd.'s (KOSDAQ:192440) Stock Prove Temporary Given Strong Fundamentals?

Dec 14
Will Weakness in Spigen Korea Co., Ltd.'s (KOSDAQ:192440) Stock Prove Temporary Given Strong Fundamentals?

Do Insiders Own Lots Of Shares In Spigen Korea Co., Ltd. (KOSDAQ:192440)?

Dec 01
Do Insiders Own Lots Of Shares In Spigen Korea Co., Ltd. (KOSDAQ:192440)?

Are Spigen Korea's (KOSDAQ:192440) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Nov 17
Are Spigen Korea's (KOSDAQ:192440) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Financial Position Analysis

Short Term Liabilities: A192440's short term assets (₩316.4B) exceed its short term liabilities (₩50.2B).

Long Term Liabilities: A192440's short term assets (₩316.4B) exceed its long term liabilities (₩7.8B).

Debt to Equity History and Analysis

Debt Level: A192440 is debt free.

Reducing Debt: A192440 has no debt compared to 5 years ago when its debt to equity ratio was 2.3%.

Debt Coverage: A192440 has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: A192440 has no debt, therefore coverage of interest payments is not a concern.

Balance Sheet

Discover healthy companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/30 13:48
End of Day Share Price 2024/12/30 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Spigen Korea Co.,Ltd is covered by 15 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kwang Jin KimCape Investment & Securities Co., Ltd.
Kevin SeoCitigroup Inc
Kyung-rae HanDaishin Securities Co. Ltd.